ABBOTT PARK, Ill., May 29, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Goldman Sachs 33rd Annual Global Healthcare Conference on Wednesday, June 6, 2012. Thomas C. Freyman, executive vice president, finance and chief financial officer and John M. Leonard, M.D., senior vice president, pharmaceuticals, research and development, will participate in a 35-minute question and answer session regarding the company beginning at 10:40 a.m. Central time.
A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at www.abbottinvestor.com. An archived edition of the presentation will be available later that day.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 91,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at www.abbott.com.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.